Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
22
04
2022
accepted:
28
02
2023
entrez:
14
3
2023
pubmed:
15
3
2023
medline:
17
3
2023
Statut:
epublish
Résumé
Timely descriptions of HIV service characteristics and their evolution over time across diverse settings are important for monitoring the scale-up of evidence-based program strategies, understanding the implementation landscape, and examining service delivery factors that influence HIV care outcomes. The International epidemiology Databases to Evaluate AIDS (IeDEA) consortium undertakes periodic cross-sectional surveys on service availability and care at participating HIV treatment sites to characterize trends and inform the scientific agenda for HIV care and implementation science communities. IeDEA's 2020 general site assessment survey was developed through a consultative, 18-month process that engaged diverse researchers in identifying content from previous surveys that should be retained for longitudinal analyses and in developing expanded and new content to address gaps in the literature. An iterative review process was undertaken to standardize the format of new survey questions and align them with best practices in survey design and measurement and lessons learned through prior IeDEA site assessment surveys. The survey questionnaire developed through this process included eight content domains covered in prior surveys (patient population, staffing and community linkages, HIV testing and diagnosis, new patient care, treatment monitoring and retention, routine HIV care and screening, pharmacy, record-keeping and patient tracing), along with expanded content related to antiretroviral therapy (differentiated service delivery and roll-out of dolutegravir-based regimens); mental health and substance use disorders; care for pregnant/postpartum women and HIV-exposed infants; tuberculosis preventive therapy; and pediatric/adolescent tuberculosis care; and new content related to Kaposi's sarcoma diagnostics, the impact of COVID-19 on service delivery, and structural barriers to HIV care. The survey was distributed to 238 HIV treatment sites in late 2020, with a 95% response rate. IeDEA's approach for site survey development has broad relevance for HIV research networks and other priority health conditions.
Identifiants
pubmed: 36917598
doi: 10.1371/journal.pone.0268167
pii: PONE-D-22-11895
pmc: PMC10013879
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0268167Subventions
Organisme : NIAID NIH HHS
ID : U01 AI096299
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069911
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069907
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069924
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069923
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI124872
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069919
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069918
Pays : United States
Informations de copyright
Copyright: © 2023 Brazier et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Int AIDS Soc. 2019 Jan;22(1):e25218
pubmed: 30657644
J Int AIDS Soc. 2013 Jan 15;16:17998
pubmed: 23336728
J Invest Dermatol. 2021 Oct;141(10):2533-2536.e2
pubmed: 33864771
J Int AIDS Soc. 2019 Jul;22(7):e25331
pubmed: 31623428
PLOS Glob Public Health. 2022;2(3):
pubmed: 36778080
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
J Int AIDS Soc. 2017 Jan 6;20(1):20933
pubmed: 28364561
PLoS One. 2020 Aug 27;15(8):e0237772
pubmed: 32853246
J Int AIDS Soc. 2018 Mar;21(3):e25101
pubmed: 29603887
J Int AIDS Soc. 2019 Sep;22(9):e25392
pubmed: 31507083
Int J STD AIDS. 2021 May;32(6):551-561
pubmed: 33530894
J Virus Erad. 2020 Feb 20;6(1):11-18
pubmed: 32175086
PLoS One. 2013 Oct 17;8(10):e77697
pubmed: 24147059
J Int AIDS Soc. 2014 Dec 15;17:19045
pubmed: 25516092